Trials / Unknown
UnknownNCT03124394
Prospective Intraperitoneal Chemotherapy in Carcinomatosis Cohort Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Kantonsspital Winterthur KSW · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of clinical outcome and economical aspects in the treatment of patients with peritoneal carcinomatosis.
Detailed description
Peritoneal carcinomatosis is a dooming finding with no hope for cure and a steadily decrease in quality of life. Cytoreductive surgery with intraperitoneal chemotherapy (CRS HIPEC) offers a small but proven chance for cure. The implementation of a CRS HIPEC and PIPAC programme in a Swiss tertiary care hospital is evaluated. When a patient is deemed non resectable, pressurized intraperitoneal aerosol chemotherapy (PIPAC) administered laparoscopically may confer effective palliation.
Conditions
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2020-12-31
- Completion
- 2020-12-31
- First posted
- 2017-04-21
- Last updated
- 2018-07-20
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT03124394. Inclusion in this directory is not an endorsement.